Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00034286
DRKS00034286
Not yet recruiting
Not Applicable

Quality assurance initiative for the treatment of breast cancer in Germany 2024

KEM Evangelische Kliniken Essen Mitte0 sites3,000 target enrollmentMay 28, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC50Malignant neoplasm of breast

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C50
Sponsor
KEM Evangelische Kliniken Essen Mitte
Enrollment
3000
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 28, 2024
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
KEM Evangelische Kliniken Essen Mitte

Eligibility Criteria

Inclusion Criteria

  • •EBC: HER2\+, TNBC or HER2\-/HR\+ UICC II or higher; surgery between April and August 2024
  • •MBC: drug\-based tumor therapy in current line; start of treatment line no more than 6 months in ago (April 2024 or later)

Exclusion Criteria

  • •Patients who are not receiving any drug\-based tumor therapy in current primary therapy or in the current MBC treatment line;
  • •Patients who are treated exclusively with osteoprotectants

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Quality Assurance Initiative on the Therapy of Bladder Cancer 2023C67Malignant neoplasm of bladder
DRKS00032582Arbeitsgemeinschaft Urologische Onkologie1,639
Not yet recruiting
Not Applicable
Quality assurance initiative for systemic treatment in metastatic colorectal cancerC18C19C20Malignant neoplasm of colonMalignant neoplasm of rectosigmoid junctionMalignant neoplasm of rectum
DRKS00033377Charite Berlin - Medizinischen Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie (CCM)2,100
Not yet recruiting
Phase 3
Study to implement nutritional diet to improve the nutritional status among patients admitted in main ICU of Nehru Hospital, PGIMER, chandigarh (2021-2023)
CTRI/2022/05/042849Main ICU Nehru Hospital PGIMER
Recruiting
Not Applicable
Quality Assurance of Invasive Measures for Treatment of Parkinson Patients in Clinical Routine in GermanyOPS 5-014.9OPS 5-028.9G20Parkinson disease
DRKS00011709Institut für Klinische Epidemiologie und Biometrie (IKE-B) Universität Würzburg1,600
Completed
Not Applicable
Quality improvement study for the prevention of post caesarean nosocomial infection in a tertiary care centreHealth Condition 1: O758- Other specified complications of labor and delivery
CTRI/2023/08/056515Post Graduate Institute of Medical Education and Research Chandigarh253